Latest updates for Boston Scientific

Fresh curated links around Boston Scientific are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system
  • Boston Scientific (BSX): Growth, Cash Flow, and Reimbursement Risk — Analysis
  • BofA Cuts PT on Boston Scientific Corporation (BSX) Over Worries for Medtech

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /1 month ago

Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system

Acquisitive Boston Scientific is making deals again, with a major investment play into a private medtech with an option to snap up exclusive rights to its Transcatheter Aortic Valv...

Read source
r-bloggers.com /1 month ago

Boston Scientific (BSX): Growth, Cash Flow, and Reimbursement Risk — Analysis

Boston Scientific (BSX) is rated Buy as double-digit growth and improving free cash flow support a premium valuation. Q1 2026 revenue rose 11.6% and EBITDA jumped 32.3%, but reimbu...

Read source
finance.yahoo.com /1 month ago

BofA Cuts PT on Boston Scientific Corporation (BSX) Over Worries for Medtech

Read source
wrtv.com /1 month ago

Boston Scientific to build $138M medical device facility in Indiana

A global leader in medical device technology has chosen central Indiana for its next medical device distribution facility.

Read source
wishtv.com /1 month ago

Boston Scientific to build $138M medical device facility in Indiana

Boston Scientific Corporation has chosen central Indiana for its next medical device distribution facility, which will create up to 300 high-wage jobs and support the state's life...

Read source
fool.com /1 month ago

Stock Market Today, May 27: Boston Scientific Plunges After Reiterating Underwhelming Full Year Growth Guidance

Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026.

Read source
orthotw.com /1 month ago

Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neuro...

Medtronic acquisition of Scientia Vascular delivers simplicity and access, supporting physicians across the full procedural workflow

Read source
fiercebiotech.com /3 weeks ago

Access Vascular taps Medline to help roll out new line of catheters

Access Vascular, a Massachusetts-based device maker that focuses on intravenous catheters, inked a partnership deal with medical supply giant Medline to help roll out a new line of...

Read source
law360.com /4 weeks ago

Fed. Circ. Affirms No Block On Stryker Spine Device In IP Fight

The Federal Circuit on Wednesday agreed with a lower court decision rejecting Boston Scientific Corp.'s request to temporarily block Stryker Corp. from launching a back pain device...

Read source
fiercebiotech.com /3 weeks ago

FDA issues early alert for J&J’s Abiomed catheter introducer over manufacturing issues, bleeding risk

The FDA has sent out an early alert to J&J’s Abiomed unit and its manufacturing partner, Oscor, for their catheter introducer kits that are used with Impella heart pumps amid m...

Read source
supplychaindive.com /4 weeks ago

Boston Scientific to build Indiana distribution center

The planned logistics site, near a principal manufacturing facility, will handle global distribution of Boston Scientific’s medical devices.

Read source
cafepharma.com /1 month ago

Clinical Specialist I

Clinical Specialist I Anonymous (not verified) Sun, 06/14/2026 - 20:54 field_thread_url https://cafepharma.com/boards/threads/clinical-specialist-i.443974/...

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

Read source
fiercebiotech.com /1 month ago

Olympus pushes deeper into oncology with $270M BioProtect deal

Olympus is pushing deeper into prostate cancer care with the acquisition of BioProtect, an Israeli company whose biodegradable balloon spacer has been used in more than 11,000 proc...

Read source
weworkremotely.com /15 hours ago

bostonscientific: Field Clinical Specialist - CRM (m/w/d)

Headquarters: Germany URL: http://bostonscientific.com   #BOSTON SCIENTIFIC     Boston Scientific verändert das Leben durch innovative medizinische Lösungen. Dabei stehen wi...

Read source
orthospinenews.com /1 month ago

Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neuro...

Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow GALWAY, Ireland, June 12, 2026 /PRNewswire/ — Medtronic…

Read source
biopharmadive.com /1 month ago

AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine

Newly published data convinced AstraZeneca to conduct a sprawling late-stage program for its GLP-1 pill. Elsewhere, Bausch + Lomb will lay off 119 employees and Cartesian boosted i...

Read source
newswire.com /1 month ago

AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform

Acquisition extends AP Technologies' vertically integrated catheter platform into nitinol and precision laser processing. Dundalk, Ireland joins the company's network of Centers of...

Read source
fool.com /1 month ago

Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months

Analysts remain relatively more upbeat, but this could prove fleeting.

Read source
weworkremotely.com /1 month ago

Abbott: Sr. Clinical Specialist, CRM - St Petersburg, FL

Headquarters: United States of America : Remote URL: http://abbott.com Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portf...

Read source
biopharmadive.com /4 weeks ago

Edgewise heart drug passes key trial test

Still, the results leave somewhat unclear how different the company’s drug is than marketed hypertrophic cardiomyopathy medicines from Bristol Myers Squibb and Cytokinetics.

Read source
pharmexec.com /1 month ago

<![CDATA[Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand St...

Read source
pehub.com /1 month ago

SK Capital-backed Spectrum Vascular picks up medical device firm Piccolo Medical

Spectrum Vascular is a provider of vascular access and medication management products. The post SK Capital-backed Spectrum Vascular picks up medical device firm Piccolo Medical app...

Read source
fiercebiotech.com /1 month ago

Endologix acquires thrombectomy system from Surmodics

Endologix, a medtech that focuses on treatments for vascular diseases, expanded its offerings with the purchase of a mechanical thrombectomy system from Surmodics.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Boston Scientific

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

orthospinenews.com

Recent coverage from public sources
Public source

ryortho.com

Recent coverage from public sources
Public source

weworkremotely.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source